#ASGCT21 is available on demand until August 13!
Access the Meeting Platform

Mary Ann Liebert, Inc.

New Rochelle,  NY 
United States

Leading research and innovation in gene and cell therapy

Mary Ann Liebert Inc. is the proud publisher of groundbreaking, peer-reviewed journals including Human Gene Therapy and The CRISPR Journal, providing all-inclusive coverage of the research, developments, and novel technologies that are driving today's explosion of gene therapy advances. Its flagship trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and remains the key driver in the growth of the industry, paving the way for the development of new technologies and applications, and  investment and career opportunities.

Brands: Human Gene Therapy, The CRISPR Journal, Genetic Engineering & Biotechnology News